-
1
-
-
84913615318
-
-
Titusville NJ: Janssen Pharmaceuticals Inc
-
Duragesic [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2012
-
(2012)
Duragesic Package Insert
-
-
-
2
-
-
0005248386
-
-
Information for healthcare professionals: Fentanyl transdermal system (marketed as Duragesic and generics Published December 21 2007. Updated September 30, 2009. Accessed August 28
-
Information for healthcare professionals: Fentanyl transdermal system (marketed as Duragesic and generics). US Food and Drug Administration Web site. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm084307.htm. Published December 21, 2007. Updated September 30, 2009. Accessed August 28, 2012
-
(2012)
US Food and Drug Administration Web Site
-
-
-
3
-
-
84876730585
-
-
REMS). US Food and Drug Administration Web site. Updated July 2012. Accessed August 28
-
Extended-release (ER) and long-acting (LA) opioid analgesics risk evaluation and mitigation strategy (REMS). US Food and Drug Administration Web site. http://www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm311290.pdf. Updated July 2012. Accessed August 28, 2012
-
(2012)
Extended-release (ER) and Long-acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy
-
-
-
5
-
-
0003413171
-
-
Washington DC: National Academy Press Accessed January 5 2014
-
Kohn LT, Corrigan J, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000. http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf. Accessed January 5, 2014
-
(2000)
To Err Is Human: Building A Safer Health System
-
-
Kohn, L.T.1
Corrigan, J.2
Donaldson, M.S.3
-
6
-
-
0029066463
-
Incidence of adverse drug events and potential adverse drug events implications for prevention
-
Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. 1995;274(1):29-34
-
(1995)
JAMA
, vol.274
, Issue.1
, pp. 29-34
-
-
Bates, D.W.1
Cullen, D.J.2
Laird, N.3
-
7
-
-
57149113185
-
ASHP national survey on informatics: Assessment of the adoption and use of pharmacy informatics in US hospitals
-
Pederson CA, Gumpper KF. ASHP national survey on informatics: Assessment of the adoption and use of pharmacy informatics in US hospitals. Am J Health Syst Pharm. 2008;65:2244-2464
-
(2008)
Am J Health Syst Pharm
, vol.65
, pp. 2244-2464
-
-
Pederson, C.A.1
Gumpper, K.F.2
-
9
-
-
76149096526
-
Launching hitech
-
Blumenthal D. Launching HITECH. N Engl J Med. 2010;362:382-385
-
(2010)
N Engl J Med
, vol.362
, pp. 382-385
-
-
Blumenthal, D.1
-
10
-
-
35648934133
-
ISMP medication error report analysis: Ongoing incidents involving fentanyl patches are alarming; Insulin concentrate u-500; Who: Dilute vincristine in a minibag
-
Cohen MR, Smetzer JL. ISMP Medication Error Report Analysis: Ongoing incidents involving fentanyl patches are alarming; Insulin concentrate U-500; WHO: dilute vincristine in a minibag. Hosp Pharm. 2007;42(10):884-888
-
(2007)
Hosp Pharm
, vol.42
, Issue.10
, pp. 884-888
-
-
Cohen, M.R.1
Smetzer, J.L.2
-
11
-
-
33646444297
-
Is the use of transdermal fentanyl inappropriate according to the who guidelines and the eapc recommendations? A study of cancer patients in Italy
-
Ripamonti C, Fagnoni E, Campa T, et al. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations?. A study of cancer patients in Italy. Support Care Cancer. 2006;14(5):400-407
-
(2006)
Support Care Cancer
, vol.14
, Issue.5
, pp. 400-407
-
-
Ripamonti, C.1
Fagnoni, E.2
Campa, T.3
-
12
-
-
70349745416
-
Frequency of longacting opioid analgesic initiation in opioid-naïve nursing home residents
-
Dosa AM, Dore DD, Mor V, Teno JM. Frequency of longacting opioid analgesic initiation in opioid-naïve nursing home residents. J Pain Symptom Manage. 2009;38(4):515-521
-
(2009)
J Pain Symptom Manage
, vol.38
, Issue.4
, pp. 515-521
-
-
Dosa, A.M.1
Dore, D.D.2
Mor, V.3
Teno, J.M.4
-
13
-
-
84856266945
-
Utilisation of transdermal fentanyl in germany from 2004 to 2006
-
Garbe E, Jobski K, Schmid U. Utilisation of transdermal fentanyl in Germany from 2004 to 2006. Pharmacoepidemiol Drug Saf. 2012;21(2):191-198
-
(2012)
Pharmacoepidemiol Drug Saf
, vol.21
, Issue.2
, pp. 191-198
-
-
Garbe, E.1
Jobski, K.2
Schmid, U.3
-
14
-
-
84873473756
-
Pharmacy-based medication reconciliation program utilizing pharmacists and technicians: A process improvement initiative
-
Smith SB, Mango Md. Pharmacy-based medication reconciliation program utilizing pharmacists and technicians: A process improvement initiative. Hosp Pharm. 2013; 48(2):112-119
-
(2013)
Hosp Pharm
, vol.48
, Issue.2
, pp. 112-119
-
-
Smith, S.B.1
Mango Md.2
-
15
-
-
73649116397
-
Medication reconciliation at an academic medical center: Implementation of a comprehensive program from admission to discharge
-
Murphy EM, Oxencis CJ, Klauck JA, et al. Medication reconciliation at an academic medical center: Implementation of a comprehensive program from admission to discharge. Am J Health Syst Pharm. 200966(23):2126-2131
-
(2009)
Am J Health Syst Pharm
, vol.66
, Issue.23
, pp. 2126-2131
-
-
Murphy, E.M.1
Oxencis, C.J.2
Klauck, J.A.3
-
16
-
-
33744482871
-
-
January 1, 2014. Accessed February 23
-
National Patient Safety Goals effective January 1, 2014. http://www.jointcommission.org/assets/1/6/HAP-NPSG- Chapter-2014.pdf. Accessed February 23, 2014
-
(2014)
National Patient Safety Goals Effective
-
-
-
17
-
-
80955140381
-
Pharmacist documentation of fentanyl patch orders in an academic medical center
-
Jahansouz F, Hsiao J, Dhillon K, et al. Pharmacist documentation of fentanyl patch orders in an academic medical center. Hosp Pharm. 2011;46(11):854-863
-
(2011)
Hosp Pharm
, vol.46
, Issue.11
, pp. 854-863
-
-
Jahansouz, F.1
Hsiao, J.2
Dhillon, K.3
|